Elizabeth Forbes

1.1k citations
11 papers · 900 indexed · h-index 10
Topics
IL-33, ST2, and ILC Pathways (5 papers)Asthma and respiratory diseases (5 papers)Eosinophilic Esophagitis (5 papers)

In The Last Decade

Elizabeth Forbes

11 papers receiving 884 citations

Peers

Elizabeth Forbes
Comparison fields: 5 of 95
  • Immunology 405
  • Surgery 287
  • Physiology 232
  • Immunology and Allergy 194
  • Rheumatology 180
Replace Kazumoto Katagiri with:
Kazumoto Katagiri Japan
Suzanne Chartier Canada
KI Matthaei Australia
Valsamma Abraham United States
Joichiro Hayashi Japan
Juan Manuel Leyva-Castillo United States
Katarzyna Gawron Poland
Wenming Peng Germany
Hidenori Yokoi Japan
Lucia Kuffová United Kingdom
Elizabeth Forbes relative to Kazumoto Katagiri Japan Kazumoto Katagiri's profile →
Citations per field
00.5×3.5×
Kazumoto Katagiri · 1×
Citations per year

Countries citing papers authored by Elizabeth Forbes

Since Specialization
Citations

This map shows the geographic impact of Elizabeth Forbes's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Elizabeth Forbes with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Elizabeth Forbes more than expected).

Fields of papers citing papers by Elizabeth Forbes

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Elizabeth Forbes. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Elizabeth Forbes. The network helps show where Elizabeth Forbes may publish in the future.

Co-authorship network of co-authors of Elizabeth Forbes

This figure shows the co-authorship network connecting the top 25 collaborators of Elizabeth Forbes. A scholar is included among the top collaborators of Elizabeth Forbes based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Elizabeth Forbes. Elizabeth Forbes is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

11 of 11 papers shown
#WorkIndexed citations
1 79
2 31
3 130
4 228
5 45
6 14
7 133
8 21
9 21
10 197
11 1

About Elizabeth Forbes

Elizabeth Forbes is a scholar working on Immunology and Allergy, Immunology and Rheumatology, having authored 11 papers that have together received 900 indexed citations. Recurring topics across this work include IL-33, ST2, and ILC Pathways (5 papers), Asthma and respiratory diseases (5 papers) and Eosinophilic Esophagitis (5 papers). The work is most often cited by research in Immunology and Allergy (194 citations), Immunology (405 citations) and Rheumatology (180 citations). Elizabeth Forbes has collaborated with scholars based in United States, Australia and New Zealand. Frequent co-authors include Simon P. Hogan, Klaus I. Matthaei, Paul S. Foster, Irving M. Shapiro, Ellis E. Golub, Chun‐Hsi Chung, Marc E. Rothenberg, Richard Ahrens, James J. Lee and Luqman Seidu. Their work appears in journals such as The Journal of Experimental Medicine, The Journal of Immunology and Gastroenterology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026